Dashboard
Manage Tickers

QDEL QUIDEL CORP /DE/

Nasdaq www.quidel.com


$ 20.36 $ -0.91 (-4.28 %)    

Friday, 07-Nov-2025 15:59:58 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 20.35
$ 21.01
$ 20.00 x 11
$ 23.23 x 23
$ 20.10 - $ 21.57
$ 20.10 - $ 49.45
3,301,351
na
851.61M
$ 0.77
$ 0.85
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-04-2022 03-31-2022 10-Q
2 02-18-2022 12-31-2021 10-K
3 11-04-2021 09-30-2021 10-Q
4 08-05-2021 06-30-2021 10-Q
5 05-07-2021 03-31-2021 10-Q
6 02-19-2021 12-31-2020 10-K
7 10-30-2020 09-30-2020 10-Q
8 07-31-2020 06-30-2020 10-Q
9 05-07-2020 03-31-2020 10-Q
10 02-13-2020 12-31-2019 10-K
11 10-31-2019 09-30-2019 10-Q
12 08-09-2019 06-30-2019 10-Q
13 05-09-2019 03-31-2019 10-Q
14 02-15-2019 12-31-2018 10-K
15 11-07-2018 09-30-2018 10-Q
16 08-08-2018 06-30-2018 10-Q
17 05-09-2018 03-31-2018 10-Q
18 02-27-2018 12-31-2017 10-K
19 11-02-2017 09-30-2017 10-Q
20 07-27-2017 06-30-2017 10-Q
21 04-27-2017 03-31-2017 10-Q
22 02-16-2017 12-31-2016 10-K
23 10-28-2016 09-30-2016 10-Q
24 07-28-2016 06-30-2016 10-Q
25 04-29-2016 03-31-2016 10-Q
26 02-23-2016 12-31-2015 10-K
27 10-29-2015 09-30-2015 10-Q
28 07-23-2015 06-30-2015 10-Q
29 04-24-2015 03-31-2015 10-Q
30 02-24-2015 12-31-2014 10-K
31 10-24-2014 09-30-2014 10-Q
32 07-24-2014 06-30-2014 10-Q
33 04-25-2014 03-31-2014 10-Q
34 02-27-2014 12-31-2013 10-K
35 10-25-2013 09-30-2013 10-Q
36 07-31-2013 06-30-2013 10-Q
37 04-24-2013 03-31-2013 10-Q
38 02-22-2013 12-31-2012 10-K
39 10-29-2012 09-30-2012 10-Q
40 07-27-2012 06-30-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-underweight-on-quidelortho-lowers-price-target-to-22
JP Morgan Maintains Underweight on QuidelO...
11/07/2025 20:28:02

JP Morgan analyst Casey Woodring maintains QuidelOrtho (NASDAQ:QDEL) with a Underweight and lowers the price target from $26...

ubs-maintains-neutral-on-quidelortho-raises-price-target-to-31
UBS Maintains Neutral on QuidelOrtho, Rais...
11/06/2025 17:54:30

UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and raises the price target from $26 to $31.

quidelortho-lowers-fy2025-adj-eps-guidance-from-207-257-to-200-215-vs-222-est-narrows-fy2025-sales-guidance-from-2600b-2810b-to-2680b-2740b-vs-2702b-est
QuidelOrtho Lowers FY2025 Adj EPS Guidance...
11/05/2025 21:14:32

QuidelOrtho (NASDAQ:QDEL) lowers FY2025 Adj EPS guidance from $2.07-$2.57 to $2.00-$2.15 vs $2.22 analyst estimate. Narrows FY2...

quidelortho-q3-adj-eps-080-beats-046-estimate-sales-699900m-beat-664961m-estimate
QuidelOrtho Q3 Adj. EPS $0.80 Beats $0.46 ...
11/05/2025 21:11:44

QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.46 by ...

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

quidelortho-receives-fda-510k-clearance-for-vitros-immunodiagnostic-products-hs-troponin-i-assay
QuidelOrtho Receives FDA 510(k) Clearance ...
11/03/2025 12:17:45

why-is-co-diagnostics-stock-sinking-tuesday
Why Is Co-Diagnostics Stock Sinking Tuesday?
10/28/2025 15:50:49

Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns ab...

reported-earlier-quidelortho-highlights-fda-approved-mts-dat-card-and-ortho-vision-platform-advancing-transfusion-medicine-at-aabb-2025
Reported Earlier, QuidelOrtho Highlights F...
10/17/2025 05:59:17

FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion ...

amd-to-rally-more-than-47-here-are-10-top-analyst-forecasts-for-tuesday
AMD To Rally More Than 47%? Here Are 10 To...
10/07/2025 12:13:15

citigroup-downgrades-quidelortho-to-neutral-lowers-price-target-to-33
Citigroup Downgrades QuidelOrtho to Neutra...
10/07/2025 11:25:09

Citigroup analyst Patrick Donnelly downgrades QuidelOrtho (NASDAQ:QDEL) from Buy to Neutral and lowers the price target from...

quidelortho-expands-quickvue-portfolio-with-launch-of-influenza-plus-sars-test-delivering-results-in-as-fast-as-10-minutes
QuidelOrtho Expands QUICKVUE Portfolio Wit...
09/22/2025 11:13:00

Key Features and Benefits:Triple Detection Capability: Differentiates influenza A/B and COVID-19 in one test.Fast Results: Clea...

ubs-maintains-neutral-on-quidelortho-lowers-price-target-to-26
UBS Maintains Neutral on QuidelOrtho, Lowe...
08/07/2025 17:37:50

UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $29 to $26.

citigroup-maintains-buy-on-quidelortho-lowers-price-target-to-40
Citigroup Maintains Buy on QuidelOrtho, Lo...
08/06/2025 21:56:43

Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Buy and lowers the price target from $50 to $40.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 21:07:20

quidelortho-affirms-fy2025-adj-eps-guidance-of-207-257-vs-240-est-affirms-fy2025-sales-guidance-of-2600b-2810b-vs-2714b-est
QuidelOrtho Affirms FY2025 Adj EPS Guidanc...
08/05/2025 20:21:23

QuidelOrtho (NASDAQ:QDEL) affirms FY2025 Adj EPS guidance from $2.07-$2.57 to $2.07-$2.57 vs $2.40 analyst estimate. Affirms FY...

quidelortho-q2-adj-eps-012-beats-001-estimate-sales-613900m-beat-609978m-estimate
QuidelOrtho Q2 Adj. EPS $0.12 Beats $0.01 ...
08/05/2025 20:11:03

QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.01 by ...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

quidelortho-and-bhlmann-expand-access-to-fecal-biomarker-testing-with-integration-of-turbo-assays-on-vitros-platforms
QuidelOrtho And BÜHLMANN Expand Access To ...
07/14/2025 11:07:22

Gastrointestinal biomarker tests enhance patient diagnosis of IBD and pancreatic insufficiency on leading clinical chemistry pl...

crowdstrike-asana-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
CrowdStrike, Asana And Other Big Stocks Mo...
06/04/2025 09:23:53

ubs-maintains-neutral-on-quidelortho-lowers-price-target-to-29
UBS Maintains Neutral on QuidelOrtho, Lowe...
05/08/2025 18:49:21

UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $45 to $29.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION